Featured
Last news
Jaguar Health Reports Second Quarter 2025 Financials: Net Q2 2025 Revenue Up Approximately 35% Versus Net Q1 2025 Revenue
The combined net Q2 2025 revenue of approximately $3.0 million for prescription and non-prescription products, including license revenue, increased approximately 35% versus net Q1 2025 revenue of approximately $2.2 million and increased approximately 10% versus net Q2 2024 revenue of approximately $2.7 millionMytesi prescription volume increased approximately 6.5% in Q2 2025 over Q1 2025 and Mytesi prescription volume in Q2 2025 was equal to the volume in Q2 2024As announced, initial proof-of-concept results from the ongoing investigator-initiated trial in Abu Dhabi show crofelemer reduced the required total parenteral nutrition in the first participating microvillus inclusion disease (MVID) patient by up to 27% and in the first participating short bowel syndrome (SBS-IF) patient by up to 12.5%; FDA meeting resulted in planned Jaguar regulatory pathway to complete supplemental NDA strategy for crofelemer for patients with metastatic breast cancer, a population meeting orphan definition in USCompany strategy: Seek business development partnerships for license to develop and commercialize Jaguar's orphan indication products, resulting in non-dilutive funding for JaguarREMINDER: Today Jaguar to host investor webcast at 8:30 a.m. Eastern regarding Q2 2025 financials and company updates; Click here to register
Lexaria's Phase 1b GLP-1 Study Achieves Important "Last Patient Last Visit" Milestone
KELOWNA, BC / ACCESS Newswire / August 14, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to announce that its Contract Research Organization ("CRO") has completed the important study milestone known as last patent last visit ("LPLV") in Lexaria's Phase 1b glucagon-like peptide-1 ("GLP-1") study in Australia, GLP-1-H24-4 (the "Study").
ANITA & ZAHA Introduces Exclusive "Made in France" Natural Cosmetics
ANITA & ZAHA unveils a premium natural cosmetics range made in France, blending over 93% natural ingredients, luxury design, and eco-conscious values for modern, mindful beauty lovers.
Labor Smart, Inc. - Letter from the CEO Q2 2025 Shareholder Update
Labor Smart, Inc. (OTCID:LTNC) - Letter from the CEO about Q2 2025 Financial Reporting
Wirsh Unveiled Geimori T38: The True Pro-Grade Wireless Electric Portable Coffee Grinder
Innovating on-the-go grinding with uncompromised quality and effortless precision
Maison Solutions Reports Fiscal Year 2025 Financial Results
MONTEREY PARK, CALIFORNIA / ACCESS Newswire / August 14, 2025 / Maison Solutions Inc. (NASDAQ:MSS) ("Maison Solutions" or the "Company"), a U.S.-based specialty grocery retailer offering traditional Asian and international food and merchandise, today announced financial results for the fiscal year ended April 30, 2025.
Patriot.TV Adds "The David Pollack Show" Expanding it's Weekly Lineup - Riding a Wave of Victories as Viewers Abandon Legacy Media for Streaming and Truth-Based Conservative Reporting
Patriot.TV's Ascent Coincides with a Broader Industry Shift Favoring New Media Over Legacy Networks and Conservative Over Liberal Outlets.
Applied DNA Reports Third Quarter Fiscal 2025 Financial Results
STONY BROOK, NY / ACCESS Newswire / August 14, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a biotechnology company focused on providing nucleic acid production solutions for the biopharmaceutical and diagnostics industries, today reported financial results for its third quarter of fiscal 2025 ended June 30, 2025. The Company's Form 10-Q for its fiscal third quarter can be viewed on the SEC Filings page of its Investor Relations website. The Company will not host a conference call to discuss these results. Applied DNA investor relations remains available for questions at [email protected] .
Interactive Strength Inc. (Nasdaq:TRNR) Reports Second Quarter 2025 Results; Increases 2025 Pro Forma Revenue Guidance to More Than $80M
Company Reports Quarterly Revenue of $1.2 Million; Net Loss and Loss per Diluted Share of $2.2 Million and $2.13Quarterly Adjusted EBITDA Loss of $1.7 Million Reflects 40% YOY ImprovementTRNR held 29.6 Million FET tokens as of June 30, 2025 and 67.4 Million FET tokens as of August 13, 2025, with a value in excess of $50 million, representing the largest publicly traded AI-focused Digital Asset TreasuryStockholders' Equity Was $16.3 Million at Quarter End2025 Pro Forma Revenue Guidance Increased to more than $80 Million, driven by Sportstech's Stronger-Than-Expected Performance, and Fourth Quarter Profitability Guidance Reiterated
Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 20
ESTERO, FL / ACCESS Newswire / August 14, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending drug and supplement delivery technology, today announced that Kraig Higginson, Interim Chief Executive Officer of Aspire, will be presenting at the upcoming Sidoti Virtual Investor Conference on August 20 at 1:45 PM Eastern. Investors and other interested individuals may access the virtual presentation here: https://sidoti.zoom.us/webinar/register/WN_5UneWjXKTOuzgbB4wpeByg
SafeHeal(R) Receives European Marketing Approval Under MDR for Colovac(R) Anastomosis Protection Technology
Marketing approval allows imminent commercialization of the Colovac device in key EU markets
Storm makes landfall in China after raking Taiwan as typhoon
Typhoon Podul weakened to a severe tropical storm when it roared ashore in southeastern China early Thursday, state media said, after carving a path across Taiwan, shutting down businesses, grounding flights and knocking out power to thousands of homes.
At least 26 migrants dead in two shipwrecks off Italy
At least 26 migrants died Wednesday when two boats sank off the coast of Italy's Lampedusa island, with around 10 others still missing, the coastguard and UN officials said.
Massive fire burns on mountain near western Canada city
Nearly 20,000 residents of a community in western Canada were on standby Wednesday as a wildfire engulfed a mountain overlooking the city of Port Alberni, the latest area threatened in the country's second-worst fire season on record.
Musk clashes with Altman after accusing App Store of favoring OpenAI
Elon Musk has accused Apple of unfairly favoring ChatGPT on its App Store and threatened legal action, triggering a fiery exchange with OpenAI CEO Sam Altman on Tuesday.
Passwords under threat as tech giants seek tougher security
Fingerprints, access keys and facial recognition are putting a new squeeze on passwords as the traditional computer security method -- but also running into public hesitancy.
Dolphin Announces Record Q2 Revenue of $14.1 Million, up 23% YoY; Deepens Investment in Women's Sports and Affiliate Marketing
CEO believes Dolphin is undervalued, purchases approximately 1% of outstanding shares since April 2025
Nepra Foods Provides Bi-Weekly MCTO Status Report
VANCOUVER, BC / ACCESS Newswire / August 13, 2025 / Nepra Foods Inc. (CSE:NPRA)(FSE:2P6)(OTCQB:NPRFF) ("Nepra Foods" or the "Company"), announces that further to its news release dated July 30, 2025, the Company voluntarily applied for and the Company's principal regulator, the British Columbia Securities Commission (the "BCSC") granted a management cease trade order (the "MCTO") dated July 30, 2025, under National Policy 12-203 Management Cease Trade Orders ("NP 12-203") and provided the Company with an extension to file its annual financial statements for the period ended March 31, 2025, including the related management's discussion and analysis, and related certifications on or before July 29, 2025 (collectively the "Annual Financial Filings"). The deadline has now been extended to on or before September 29, 2025.
Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results
- Dermata announced additional positive data from its XYNGARI™ Phase 3 Spongilla Treatment of Acne Research (STAR-1) clinical trial-- Raised $8.8 million in gross proceeds from a private placement and warrant inducement financings during the first half of 2025 -
Desert Oasis Healthcare Supports Alzheimer's Coachella Valley and Its Upcoming "Celebration of Care" Open House
DOHC champions vital dementia support services ahead of ACV's October 29 Celebration of Care
NBJ Summit Unites Leaders to Navigate Market Disruption and Transformation
RANCHO PALOS VERDES, CA / ACCESS Newswire / August 13, 2025 / NBJ Summit 2025, the nutrition and dietary supplements industry's flagship invite-only event hosted by New Hope Network, wrapped up four days of high-impact conversations, collaborative leadership and future-focused insights. Top executives, thought leaders and industry experts convened to navigate the rapid shifts redefining the $70 billion dietary supplement industry. With the theme of "Nutrition Industry Transformation: Leading Through Innovation," the Summit arrived at a pivotal moment as the market evolves through convergence with healthcare, technology and shifting consumer expectations.
Onco-Innovations Announces Closing of Private Placement
Not for distribution to United States wire services or for dissemination in the United States
Evotec SE Reports H1 2025 Results: Strong Progress on Strategy Execution
Strategy for sustainable profitable growth progressing as planned with improving revenue mix and ahead-of-plan cost reductionsReporting segment formerly known as Shared R&D renamed to Discovery & Preclinical Development ("D&PD") to better reflect strategic focusGroup revenues of € 371.2 m (-5%); D&PD (-11%) continues to see soft demand;Just - Evotec Biologics ("JEB"; +16%) exceeding expectations driven by broadened customer baseKey progress in collaborations with Bristol Myers Squibb ("BMS") on targeted protein degradation and neuroscienceEvolution of strategic partnership with Sandoz announced on 30 July
Pivotree Announces Second Quarter 2025 Results
Strong gross margins and operational discipline delivers $1.7M of Adjusted EBITDA in Q2 2025, marking a third consecutive quarter of positive Adjusted EBITDA and second quarter of positive Net Income
Specificity Prepares to Launch Proprietary AI Tech Stack After Year of Strategic Transformation
TAMPA, FL / ACCESS Newswire / August 13, 2025 / Specificity, Inc. (OTCID:SPTY), a leading digital marketing agency blending proprietary ad tech with cutting-edge strategy, is finalizing development of its fully in-house, company-owned AI technology stack - a powerful asset set to redefine how the company scales, drives efficiency, and maintains its edge in the marketplace.
KIFFIK Biomedical Onboards Industry Leaders Rene Veloso and Dr. Reginald Swift to Expand Business and Clinical Operations
Rene Veloso, JD, MBA, joins KIFFIK to lead investor relations and secure new funding to fuel clinical operationsRubix Life Sciences CEO Reginald Swift, Ph.D. joins as Chief Scientific Officer with responsibility to shape KIFFIK's clinical strategy
Aptevo Highlights APVO442, a CD3-Directed Preclinical Candidate for Prostate Cancer
Builds on the targeted immune activation model validated by mipletamig in AML, adapted for prostate cancer.Engineered for precision T-cell activation in prostate cancer; part of Aptevo's growing CRIS-7-derived CD3 portfolio targeting both hematologic and solid tumors
Labor Smart, Inc. (OTCID:LTNC) Retires 720 Million Shares to Treasury and Secures Strategic Go Fast Sports Agreement
JACKSON, WY / ACCESS Newswire / August 13, 2025 / Labor Smart, Inc. (OTCID:LTNC), a Jackson, Wyoming-based brand acquisition and development company, today announced the immediate retirement of 720,000,000 shares to its treasury as part of a strategic transaction involving the Go Fast Sports brand.
Dolphin Forms New Division to Elevate Culinary and Lifestyle Talent
"Tastemakers" Launches as a First-of-Its-Kind Collaboration Between Dolphin Subsidiaries The Door and The Digital Dept., Pioneering New Model of Talent Management and Earned Media
Aspire Biopharma Successfully Launches BUZZ BOMB(TM) Pre-Workout Supplement at FitCon and FitExpo, Two of the Largest Fitness Conventions in the World
BUZZ BOMB™ is bringing its unique delivery technology benefits to the multi-billion-dollar pre-workout to help athletes and fitness enthusiasts maximize their performance potential30,000 BUZZ BOMB™ sample packs of four 50mg stick packs in each flavor distributed to convention attendeesWell-known fitness instructors, fitness celebrities, athletes, and influencers along with thousands of fitness enthusiasts and consumers sampled BUZZ BOMB™'s four bold flavorsAs part of its launch, Aspire plans on partnering with well-known athletes and influencers across fitness training and endurance sports to accelerate consumer awareness and uptakeBUZZ BOMB™ is available for purchase at buzzbomb.buzz, the Company's new E-commerce website
Infinite Auctions Showcases Five Pairs of Michael Jordan Game-Worn Sneakers in "The Grail Collection" Online Auction
MESA, ARIZONA / ACCESS Newswire / August 13, 2025 / Infinite Auctions, a premier sports memorabilia auction house and a subsidiary of Medical Care Technologies Inc. (OTC PINK:MDCE), is proud to present a once-in-a-lifetime offering for basketball and sneaker enthusiasts alike. As part of its highly anticipated "The Grail Collection" online auction, Infinite Auctions is featuring five pairs of game-worn sneakers from NBA legend Michael Jordan. The event is currently live at www.infiniteauctions.com and will conclude on August 30, 2025.
FriskaAi and Dexcom Enter CGM Data Integration Agreement
ARLINGTON, VA / ACCESS Newswire / August 13, 2025 / FriskaAi announced today an agreement with DexCom, Inc., the global leader in glucose biosensing, to integrate data from Dexcom G7 and Dexcom G6 Continuous Glucose Monitoring (CGM) Systems into the FriskaAi platform. Under the agreement, data from Dexcom CGMs will be integrated with Friska Ai, the company's groundbreaking AI-powered healthcare platform supporting physicians and patients with actionable personalized care management programs.